Key facts
- This page summarizes Phillip E. Lee's Form 4 filing for Vaxart, Inc. (VXRT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 30 Dec 2022, 19:21.
Phillip E. Lee - 16 Dec 2022 Form 4 Insider Report for Vaxart, Inc. (VXRT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- VXRT
- Reported as of
- 16 Dec 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 Dec 2022, 19:21:25 UTC
- Prior SEC filing
- 30 Dec 2022
- Next SEC filing
- 11 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edward Berg, Attorney-in-Fact for W. Mark Watson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Phillip E. Lee filed Form 4 for Vaxart, Inc. (VXRT) on 30 Dec 2022.
Change
- Previous filing in this sequence was filed on 30 Dec 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VXRT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +68,750
- Change %
- Price
- $0.000000
- Shares after
- 68,750
- Date
- 16 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VXRT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +412,500
- Change %
- Price
- $0.000000
- Shares after
- 412,500
- Date
- 16 Dec 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 412,500
- Exercise price
- $1.06
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Grant of shares upon vesting of restricted stock units ("RSUs"). The RSUs vest as to 25% of the shares underlying the award on each anniversary of December 15, 2022 (the "Start Date"), so that the RSUs would be fully vested on the fourth anniversary of the Start Date.
Footnote F2
The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on December 15,2023, the first anniversary of the Start Date, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on December 16, 2026.